Osteoporosis, Postmenopausal Clinical Trials

12 recruitingLast updated: May 5, 2026

There are 12 actively recruiting osteoporosis, postmenopausal clinical trials across 8 countries. Studies span Not Applicable, Phase 4. Top locations include Roma, Italy, Siena, Italy, Milan, Italy. Updated daily from ClinicalTrials.gov.


Osteoporosis, Postmenopausal Trials at a Glance

12 actively recruiting trials for osteoporosis, postmenopausal are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Roma, Siena, and Milan. Lead sponsors running osteoporosis, postmenopausal studies include 424 General Military Hospital, Massachusetts General Hospital, and Beylikduzu State Hospital.

Browse osteoporosis, postmenopausal trials by phase

Treatments under study

About Osteoporosis, Postmenopausal Clinical Trials

Looking for clinical trials for Osteoporosis, Postmenopausal? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Osteoporosis, Postmenopausal trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Osteoporosis, Postmenopausal clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Phase 4

Combined Anabolic Therapy

OsteoporosisOsteoporosis, Postmenopausal
Massachusetts General Hospital50 enrolled1 locationNCT06558188
Recruiting
Not Applicable

Mechanisms of Anabolic Osteoporosis Therapy

Osteoporosis, Postmenopausal
Massachusetts General Hospital16 enrolled1 locationNCT05688969
Recruiting
Phase 4

Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients

OsteoporosisOsteoporosis, Postmenopausal
National Taiwan University Hospital70 enrolled1 locationNCT06938152
Recruiting
Not Applicable

Effect of Mechanical Loading and Bone Loss on Motor Neuron Activity-H-Reflex Relationship

Osteoporosis, Postmenopausal
Istanbul Physical Medicine Rehabilitation Training and Research Hospital24 enrolled1 locationNCT07253493
Recruiting
Not Applicable

Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis

OsteoporosisOsteoporosis, Postmenopausal
Khyber Medical University Peshawar40 enrolled1 locationNCT07242612
Recruiting

Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)

Osteoporosis, Postmenopausal
424 General Military Hospital125 enrolled9 locationsNCT05575167
Recruiting

Sequential Therapies After Osteoanabolic Treatment

Osteoporosis, Postmenopausal
424 General Military Hospital150 enrolled8 locationsNCT06164795
Recruiting

Stress Urinary Incontinence and Sarcopenia in Postmenopausal Osteoporosis

Osteoporosis, Postmenopausal
Beylikduzu State Hospital100 enrolled1 locationNCT06655701
Recruiting

Health Literacy's Impact on Exercise Habits and Medication Adherence in Postmenopausal Osteoporosis

Osteoporosis, Postmenopausal
Gazi University60 enrolled1 locationNCT06462833
Recruiting

New Biomarkers and Therapeutic Targets in Osteoporosis Via Omics Technologies

Osteoporosis, PostmenopausalOsteoporosis FractureOsteoporosis, Severe
National and Kapodistrian University of Athens60 enrolled1 locationNCT06525688
Recruiting

Virtual perI-/Menopause Registry of AusTrALia

MenopauseHot FlashesCardiovascular Diseases+17 more
Bespoke Clinical Research10,000 enrolled1 locationNCT06487130
Recruiting
Not Applicable

Vascular Function, Sarcopenia and Pain in Postmenopausal Osteoporosis

Osteoporosis, Postmenopausal
University Hospital, Clermont-Ferrand150 enrolled1 locationNCT05228262